China’s NMPA Proposes Reforms to Enhance Radiopharmaceutical Review and Approval
China’s National Medical Products Administration (NMPA) has released a draft proposal titled “Opinions on Reforming...
Policy / Regulatory
China’s NMPA Releases 60th Batch of Reference Drugs for Generic Quality Evaluation
The National Medical Products Administration (NMPA) has released the 60th batch of reference drugs for...
China’s Volume-Based Procurement Cuts High-Value Medical Consumables Costs by 84%
The national high-value medical consumables alliance procurement office has released the results of the third...
BGI Genomics Added to US Defense Department’s Investment Ban List
BGI Genomics Co., Ltd, a leading Chinese gene sequencing firm, has reportedly been added to...
NHSA Releases Guide on Volume-Based Procurement Drug Equivalents
The National Healthcare Security Administration (NHSA) has reportedly released a reference guide for industry players,...
F-star Therapeutics’ Takeover by Sino Biopharmaceutical Delayed Amid CFIUS Review
UK-based biotech F-star Therapeutics Inc. (NASDAQ: FSTX) announced in a stock exchange press release that...
Heilongjiang Launches ‘Longjiang Huiminbao’ Supplementary Health Insurance Scheme
Heilongjiang province has launched its first provincial-level supplementary commercial health insurance scheme, branded “Longjiang Huiminbao.”...
Beijing Designates 923 Medical Entities for National Reimbursement Drug List
The Beijing Municipal Medical Insurance Bureau has released a notification indicating that a total of...
NHSA Launches Expert Review for 2025 NRDL Update in China
The National Healthcare Security Administration (NHSA) announced on September 16 the commencement of the expert...
Hainan’s Lecheng Zone Updates Special Drug Insurance List with Expanded Coverage
Hainan Boao Lecheng International Medical Tourism Pilot Zone has released an updated special drug insurance...
US Blocks Asymchem’s Acquisition of Snapdragon Chemistry
US authorities have intervened to block the purchase of US-based Contract Development and Manufacturing Organization...
CDE Issues Guidelines for Anti-Tumor ADC Clinical Development
The Center for Drug Evaluation (CDE) has released the “Technical Guidelines for Clinical Research and...
China’s Policy Shifts Medical Device Procurement Toward Domestic Products
Local government policies in China have begun to direct public hospitals to prioritize the procurement...
NMPA Releases 58th Batch of Reference Drugs for Generic Quality Consistency Evaluation
The National Medical Products Administration (NMPA) has released the 58th batch of reference drugs for...
Guangdong Launches Free HPV Vaccination Program for School-aged Girls
Guangdong province has rolled out a free HPV vaccination program this month, aimed at improving...
Hubei Province Proposes National TCM Patent Medicine Procurement Alliance
The Healthcare Security Administration of Hubei Province has proposed the establishment of a national traditional...
NMPA Issues Guidelines on Medical Device Grading Administration
The National Medical Products Administration (NMPA) has released a set of Guiding Opinions on “Medical...
Frontier Biotech’s FB2001 Inhalant Accepted for NMPA Review
China-based Frontier Biotechnologies Inc. (SHA: 688221) announced that a registrational clinical filing for its FB2001...
Biden’s Executive Order Boosts US Bio-Economy, Targets China’s Biotech Rise
US President Joe Biden signed an executive order on Monday, outlining steps to bolster the...
Jiangsu Healthcare to Cover All Psychological Treatments Under BMI
The Jiangsu Provincial Healthcare Security Administration is reportedly considering adding all psychological diagnosis and treatment...